Arthur Tzianabos, Interim Executive Chair at Stoke Therapeutics, Inc. (STOK), sold 8,710 shares at $40.00 ($348K) on 2026-03-10, disclosed to the SEC on 2026-03-12.
Open-market sale of $348k STOK by Interim Executive Chair. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 4,355 | $174K | 50.0% |
| 2 | $40.00 | 4,355 | $174K | 50.0% |
| Total | $40.00 avg | 8,710 | $348K | 100% |
| Filing → |
| FIXX | SELL | 2023-01-11 | $15K | — | Filing → |
| FIXX | SELL | 2022-01-12 | $20K | — | Filing → |
| STOK | SELL | 2021-02-23 | $607K | — | Filing → |